Skip to main content
. 2009 Jun 29;53(9):3675–3682. doi: 10.1128/AAC.00550-09

TABLE 3.

Antimicrobial susceptibilities of M. bovis BCG P55 strains

Compound MIC (mg/liter) for M. bovis BCG straina:
Wild type KOP55b KOP55 PAZ23c PAZ23d
Bacitracin >256 16 >256 NDf
Bacitracin + CCCPe >256 16 >256
CCCP 4 2 ND ND
Clofazimine 0.1 0.025 0.1 0.1
Chlorpromazine 4 4 ND ND
Econazole 6.4 1.6 6.4 12.8
Ethambutol 4 2 ND ND
Novobiocin 16 2 16 ND
Novobiocin + CCCPe 4 1 4
Novobiocin + VALe 8 0.5 8
Novobiocin + RPe 16-8 1 16-8
PA-824 0.25 0.125 0.25 ND
Reserpine 2 2 2 ND
Rifampin 0.0032 0.0004 0.0032 0.0032
Rifampin + CCCPe 0.0008 0.0002 0.0008
Rifampin + VALe 0.0016 0.0002 0.0016
Rifampin + RPe 0.0032-0.0016 0.0004 0.0032-0.0016
Valinomycin 0.4 0.2 0.4 ND
Vancomycin 4 0.25 4 8
Vancomycin + CCCPe 4 0.25 4
Triclosan 8 8 ND ND
a

MICs were assayed over a range of twofold dilutions of antibiotics. The MICs of clofazimine, chlorpromazine, econazole, and triclosan were determined on agar plates. The MICs of bacitracin, CCCP, ethambutol, novobiocin, reserpine, rifampin, valinomycin, and vancomycin were determined by the resazurin assay. No difference in susceptibility between wild-type and KOP55 strains was observed for the following compounds: acriflavine, amikacin, cerulenin, d-cycloserine, ethidium bromide, ciprofloxacin, chloramphenicol, ethionamide, fluconazole, gentamicin, imipenem, isoniazid, ofloxacin, p-aminosalicylic acid, streptomycin, spectinomycin, and tetracycline (data not shown).

b

KOP55 is M. bovis BCG with the p55 gene inactivated.

c

KOP55 PAZ23 is complemented M. bovis BCG KOP55 with plasmid pPAZ23 (p27-p55 operon cloned into pSUM41).

d

PAZ23 is M. bovis BCG containing plasmid pPAZ23 (p27-p55 operon in pSUM36).

e

CCCP, valinomycin (VAL), and reserpine (RP) were present at concentrations of 1, 0.1, and 0.5 mg/liter, respectively (fourfold the sub-MIC for the M. bovis BCG wild type).

f

ND, not determined.